166 related articles for article (PubMed ID: 1823854)
1. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
[TBL] [Abstract][Full Text] [Related]
2. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
Hoefnagel CA; Taal BG; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
Colombo L; Vignati A; Lomuscio G; Dottorini ME
J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
[TBL] [Abstract][Full Text] [Related]
4. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
[TBL] [Abstract][Full Text] [Related]
5. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
[TBL] [Abstract][Full Text] [Related]
6. The role of [131I]metaiodobenzylguanidine in the treatment of medullary thyroid carcinoma: results in five cases.
Troncone L; Rufini V; Maussier ML; Valenza V; Daidone MS; Luzi S; De Santis M
J Nucl Biol Med (1991); 1991; 35(4):327-31. PubMed ID: 1823849
[TBL] [Abstract][Full Text] [Related]
7. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
[TBL] [Abstract][Full Text] [Related]
8. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
9. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
Schvartz C; Gibold C; Vuillemin B; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
[TBL] [Abstract][Full Text] [Related]
10. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
[TBL] [Abstract][Full Text] [Related]
11. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
Bestagno M
J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
[No Abstract] [Full Text] [Related]
12. [131I]metaiodobenzylguanidine therapy in paraganglioma.
Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
[TBL] [Abstract][Full Text] [Related]
13. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
[TBL] [Abstract][Full Text] [Related]
15. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
[TBL] [Abstract][Full Text] [Related]
16. Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
Shapiro B; Sisson JC; Wieland DM; Mangner TJ; Zempel SM; Mudgett E; Gross MD; Carey JE; Zasadny KR; Beierwaltes WH
J Nucl Biol Med (1991); 1991; 35(4):269-76. PubMed ID: 1823834
[TBL] [Abstract][Full Text] [Related]
17. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Castellani MR; Rottoli L; Maffioli L; Massimino M; Gasparini M; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):241-3. PubMed ID: 1726677
[TBL] [Abstract][Full Text] [Related]
18. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
[TBL] [Abstract][Full Text] [Related]
19. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
Hoefnagel CA; Delprat CC; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851
[TBL] [Abstract][Full Text] [Related]
20. [131I]metaiodobenzylguanidine therapy in medullary thyroid cancer: Guy's Hospital experience.
Clarke SE
J Nucl Biol Med (1991); 1991; 35(4):323-6. PubMed ID: 1823848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
